Aberdeen Group Portfolio holdings
AUM
$58.8B
1-Year Return
21.66%
This Quarter Return
+12.43%
1 Year Return
+21.66%
3 Year Return
+94.43%
5 Year Return
+162.75%
10 Year Return
–
AUM
$46.1B
AUM Growth
+$6.94B
(+18%)
Cap. Flow
+$2.42B
Cap. Flow
% of AUM
5.24%
Top 10 Holdings %
Top 10 Hldgs %
24.2%
Holding
995
New
107
Increased
596
Reduced
238
Closed
35
Top Buys
| 1 |
NVIDIA
NVDA
|
$247M |
| 2 |
Amgen
AMGN
|
$181M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$164M |
| 4 |
Johnson & Johnson
JNJ
|
$161M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$157M |
Top Sells
| 1 |
Broadcom
AVGO
|
$244M |
| 2 |
Microsoft
MSFT
|
$221M |
| 3 |
Emerson Electric
EMR
|
$205M |
| 4 |
TJX Companies
TJX
|
$204M |
| 5 |
Fiserv
FI
|
$185M |
Sector Composition
| 1 | Technology | 27.07% |
| 2 | Healthcare | 17.55% |
| 3 | Financials | 10.75% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
IHS Holding
IHS
$2.44B
| $2.05M | ﹤0.01% |
444,883
| – | – |
|
777
CubeSmart
CUBE
$9.52B
| $1.99M | ﹤0.01% |
42,920
-4,245
| -9% | -$197K |
|
778
Blue Owl Capital
OBDC
$7.33B
| $1.97M | ﹤0.01% |
133,141
+36,006
| +37% | +$531K |
|
|
GMRE
779
Global Medical REIT
GMRE
$508M
| $1.94M | ﹤0.01% |
+174,897
| New | +$1.94M |
|
|
GTM
780
ZoomInfo Technologies
GTM
$3.26B
| $1.87M | ﹤0.01% |
100,875
-763,651
| -88% | -$14.1M |
|
781
Assurant
AIZ
$10.7B
| $1.85M | ﹤0.01% |
11,002
+5,997
| +120% | +$1.01M |
|
782
Varonis Systems
VRNS
$6.28B
| $1.83M | ﹤0.01% |
40,348
-875
| -2% | -$39.6K |
|
783
iShares MSCI Ireland ETF
EIRL
$60.4M
| $1.79M | ﹤0.01% |
29,205
-4,061
| -12% | -$248K |
|
784
GDS Holdings
GDS
$6.35B
| $1.76M | ﹤0.01% |
193,008
-10,400
| -5% | -$94.8K |
|
785
Fulcrum Therapeutics
FULC
$414M
| $1.73M | ﹤0.01% |
+256,888
| New | +$1.73M |
|
786
Masimo
MASI
$8B
| $1.68M | ﹤0.01% |
14,334
+6,862
| +92% | +$804K |
|
787
Akero Therapeutics
AKRO
$3.58B
| $1.67M | ﹤0.01% |
+71,542
| New | +$1.67M |
|
788
Edgewise Therapeutics
EWTX
$1.64B
| $1.65M | ﹤0.01% |
+150,418
| New | +$1.65M |
|
789
EastGroup Properties
EGP
$8.97B
| $1.61M | ﹤0.01% |
8,754
-476
| -5% | -$87.4K |
|
790
Blackstone Secured Lending
BXSL
$6.72B
| $1.59M | ﹤0.01% |
57,497
+16,852
| +41% | +$466K |
|
791
Amcor
AMCR
$19.1B
| $1.58M | ﹤0.01% |
164,363
+33,792
| +26% | +$326K |
|
792
Westlake Corp
WLK
$11.5B
| $1.57M | ﹤0.01% |
11,223
+5,628
| +101% | +$788K |
|
793
Fox Class B
FOX
$24.9B
| $1.55M | ﹤0.01% |
56,137
+22,956
| +69% | +$635K |
|
794
GSK
GSK
$81.5B
| $1.55M | ﹤0.01% |
+41,852
| New | +$1.55M |
|
795
JD.com
JD
$44.6B
| $1.55M | ﹤0.01% |
53,544
+659
| +1% | +$19K |
|
796
GlobalFoundries
GFS
$18.5B
| $1.53M | ﹤0.01% |
26,004
+15,610
| +150% | +$917K |
|
|
LSXMK
797
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.52M | ﹤0.01% |
52,965
+26,702
| +102% | +$768K |
|
798
Liberty Global Class C
LBTYK
$4.12B
| $1.52M | ﹤0.01% |
81,473
+39,199
| +93% | +$731K |
|
799
Takeda Pharmaceutical
TAK
$48.6B
| $1.5M | ﹤0.01% |
+105,073
| New | +$1.5M |
|
800
Xenon Pharmaceuticals
XENE
$3.02B
| $1.48M | ﹤0.01% |
+32,036
| New | +$1.48M |
|